KB Financial Partners’s Abiomed Inc ABMD Stock Holding History

KB Financial Partners’s Portfolio ABMD Stock Details ABMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-303	Closed	-$74K	–	610
2022 Q3	$74K	Sell	303 -36	-11%	-$9.72K	0.03%	220
2022 Q2	$84K	Buy	339 +87	+35%	+$23.5K	0.03%	222
2022 Q1	$83K	Buy	+252	New	+$77.6K	0.02%	236

Other funds holding ABMD

TRSOTSOK

Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

KB Financial Partners's ABMD Position: Q4 2022 in Review

KB Financial Partners sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 303 shares — an estimated $74K sold.

KB Financial Partners first reported a position in ABMD in Q1 2022 and held it in 3 quarters. The position peaked at $84K in Q2 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

KB Financial Partners reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
KB Financial Partners sold 303 Abiomed Inc shares in Q4 2022, an estimated $74K.
KB Financial Partners first reported a position in Abiomed Inc in Q1 2022 and held it in 3 quarters.
KB Financial Partners's Abiomed Inc position peaked at $84K in Q2 2022.
8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on KB Financial Partners's 13F filing for Q4 2022, filed 21 Feb 2023.